GHO Capital, CBC Group to merge, forming what could be the largest healthcare specialist investor

Reynald Castaneda / endpoints - European healthcare investor GHO Capital and asset management firm CBC Group are set to join forces, with the new entity to manage over $21 billion. In a Wednesday release, they said ...

AI Summary: GHO Capital and CBC Group have agreed to combine their healthcare investment platforms to create roughly a $21 billion specialist investor focused on health assets. The tie-up consolidates capital and deal teams to chase larger transactions across care delivery, pharma and tech—because apparently healthcare needed a bigger private-equity behemoth.

#healthcare #pharmaceuticals #mergersandacquisitions #digitalhealth #healthcarefinance #venturecapital

M&A as a Precision Instrument: How an $18B+ Dealmaking Wave Is Rewiring Oncology Against the Patent Cliff

6 wks / oncodaily

Opinion: Increased oversight of private equity in health care is needed to protect patients and the physician workforce

6 wks / medicalxpress

GHO Capital, CBC Group Combine to Form $21B Healthcare Investment Giant

7 wks / medcitynews / Katie Adams

GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm

7 wks / fiercehealthcare

GHO Capital, CBC Group to merge, forming what could be the largest healthcare specialist investor

7 wks / endpoints / Reynald Castaneda

Common asthma drug helps fight hard-to-treat cancers, including aggressive breast cancers, early study finds

livescience - Scientists found that blocking a protein best known for its role in asthma enhances cancer immunotherapy in preclinical models.

AI Summary: Early studies report that a widely used asthma medication can switch off a tumor immune‑evasion pathway and restore anti‑tumor immunity in models and early human data, improving responses in some hard‑to‑treat cancers including aggressive breast tumours. Researchers call for larger trials to confirm clinical benefit and safety.

#pharmaceuticals #biotech #drugdevelopment #oncology #cancerresearch #clinicaltrials

Asthma drug revives anti‑tumor immunity in resistant cancers (5)
Mechanisms and meetings on immunotherapy resistance (5)
All Other Stories

6 wks / nature

GraphTME: graph-based framework for predicting immunotherapy response by interpreting tumour microenvironment interactions using spatial transcriptomics

6 wks / nature

Breast tumors use sugar coating to evade immunity, opening potential immunotherapy path

6 wks / medicalxpress

New drug targets pancreatic cancer immunotherapy resistance

6 wks / beckershospitalreview / Ella Jeffries

Cassio Murilo T Hidalgo Filho: Overcoming Primary and Acquired Resistance to Immunotherapy in NSCLC

6 wks / oncodaily

Erratum for the Research Article “In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy”

7 wks / science

Toronto Rock take NLL Cup with win over Halifax Thunderbirds

Denio Lourenco / citynews - Owen Hiltz and Chris Boushy each had three goals and an assist, Mark Matthews had a goal and three assists, and Nick Rose made 34 saves as the Toronto Rock defeated the Halifax Thunderbirds 12-7 to win the National Lacrosse League championship on Sunday a…

AI Summary: A clinical study shows that delivering just two ablative radiotherapy sessions over eight days achieves effective control of localized prostate cancer without adding side effects, offering a dramatically shorter, patient‑friendly regimen. If adopted more widely, the approach could reduce treatment burden, clinic visits and health‑system costs while maintaining cancer control.

#healthcare #oncology #healthcarefinance #cancerresearch #clinicaltrials

Sushil Beriwal: Siemens Healthineers Lunch Session Advancing Cutting Edge Brachytherapy Techniques

6 wks / oncodaily

Local Treatment for Prostate Cancer Recurrence After Radiotherapy

6 wks / oncodaily

Does ceramide lipid metabolism affect response to prostate cancer drugs?

6 wks / medicalxpress

10 Must-Read Posts In GU Oncology This Week

6 wks / oncodaily

Sean Collins: Iodinated Rectal Spacers Improve Bladder Dose Constraints in Prostate SBRT

6 wks / oncodaily

David Sher: FASTRACKII Final Results at ESTRO26 in Prostate Cancer